These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4865582)

  • 21. [Combined action of alpha-chymotrypsin and testicular hyaluronidase on the take of the homotransplant of a spontaneous mammary adenocarcinoma in Swiss mice].
    Delfino Pesce V
    Boll Soc Ital Biol Sper; 1967 May; 43(10):554-6. PubMed ID: 6056668
    [No Abstract]   [Full Text] [Related]  

  • 22. Tumor-specific antigen(s) in a spontaneous mammary carcinoma of C3H mice. II. Active immunization of mammary-tumor-agent-free mice.
    Suit HD; Silobrcic V
    J Natl Cancer Inst; 1967 Dec; 39(6):1121-8. PubMed ID: 6079865
    [No Abstract]   [Full Text] [Related]  

  • 23. [Changes in antitumor resistance during chemical carcinogenesis].
    Savinskaia AP
    Biull Eksp Biol Med; 1984 Aug; 98(8):226-8. PubMed ID: 6432073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dietary amino acids on tumour growth and cell-mediated immune responses.
    Bounous G; Sadarangani C; Pang KC; Kongshavn PA
    Clin Invest Med; 1981; 4(2):109-15. PubMed ID: 7026098
    [No Abstract]   [Full Text] [Related]  

  • 25. Retarded immunological recovery in sublethally x-irradiated mice by additional thymic exposure. Reversal with injected marrow cells. NRDL-TR-68-119.
    Davis WE; Cole LJ
    Res Dev Tech Rep; 1968 Sep; ():1-14. PubMed ID: 4890100
    [No Abstract]   [Full Text] [Related]  

  • 26. Ability of normal bone marrow to restore second-set immunity.
    Kongshavn PA; Lapp WS; Hinchey EJ
    Transplant Proc; 1971 Mar; 3(1):437-9. PubMed ID: 4937913
    [No Abstract]   [Full Text] [Related]  

  • 27. Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. 3. Plaque-forming cell response in lymph nodes and spleen.
    Rowland GF; Edwards AJ; Hurd CM; Sumner MR
    J Natl Cancer Inst; 1971 Aug; 47(2):321-7. PubMed ID: 4934422
    [No Abstract]   [Full Text] [Related]  

  • 28. Growth of an allogeneic tumor in lethally irradiated mice treated with sensitized and unsensitized spleen cells.
    Riches AC; Thomas DB
    Radiat Res; 1970 Oct; 44(1):87-96. PubMed ID: 5473401
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas.
    Simmons RL; Rios A
    J Immunol; 1973 Dec; 111(6):1820-5. PubMed ID: 4750868
    [No Abstract]   [Full Text] [Related]  

  • 30. Syngeneic preference and allogeneic inhibition.
    Hellström KE; Hellström I
    Wistar Inst Symp Monogr; 1965 Aug; 3():79-93. PubMed ID: 5884667
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of thymus in adoptive tolerance.
    Argyris BF
    J Immunol; 1968 Jun; 100(6):1255-8. PubMed ID: 4880143
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of an immunoresistant and an immunosusceptible ascites subline from murine tumor TA3. I. Transplantability, morphology, and some physicochemical characteristics.
    Friberg S
    J Natl Cancer Inst; 1972 May; 48(5):1463-76. PubMed ID: 5030958
    [No Abstract]   [Full Text] [Related]  

  • 33. Delayed mortality in sublethally irradiated mice treated with allogeneic lymphoid and myeloid cells.
    Boranić M
    J Natl Cancer Inst; 1968 Aug; 41(2):439-50. PubMed ID: 4876446
    [No Abstract]   [Full Text] [Related]  

  • 34. Normal tissue antigens of tumor cells.
    Milas L; Suit HD
    Tex Rep Biol Med; 1969; 27(2):467-9. PubMed ID: 4900374
    [No Abstract]   [Full Text] [Related]  

  • 35. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
    Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
    Asavaroengchai W; Kotera Y; Koike N; Pilon-Thomas S; Mulé JJ
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):524-33. PubMed ID: 15282530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance induction in adult mice with tumor homografts.
    Wachtel SS; Silvers WK
    Transplantation; 1971 Jul; 12(1):61-4. PubMed ID: 4932698
    [No Abstract]   [Full Text] [Related]  

  • 38. Two phenomena associated with skin grafting from tumor-bearing syngeneic donors.
    Svet-Moldavsky GJ; Mkheidze DM; Liozner AL
    J Natl Cancer Inst; 1967 Jun; 38(6):933-8. PubMed ID: 5338527
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD; Padmanabhan R; Lopez DM
    Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient graft-versus-host reaction in the treatment of leukemia in mice.
    Boranić M
    J Natl Cancer Inst; 1968 Aug; 41(2):421-37. PubMed ID: 4876445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.